CliffBio
small molecule

TIROFIBAN HYDROCHLORIDE

TIROFIBAN HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyNexus Labs →See this company's full patent-cliff portfolio

Drug detail

Brand nameTIROFIBAN HYDROCHLORIDE
Active ingredientTIROFIBAN HYDROCHLORIDE
StrengthEQ 12.5MG BASE/250ML (EQ 0.05MG BASE/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalJuly 2023
Marketing statusRX

More from Nexus Labs

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

TIROFIBAN HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio